Biobanking Market Trends

  • Report ID: 4602
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Biobanking Market Growth Drivers and Challenges:

Growth Drivers

  • Growing Research Activities Associated with Genomics - As per the World Health Organization (WHO), as a result of significant investments made during the COVID-19 pandemic, the percentage of countries capable of carrying out genomic surveillance expanded from 54% to 68% between March 2021 and January 2022.

  • Genomics research is the study of full genetics along with the complement of an organism. It is generally conducted to prepare personalized medicines and focus on the editing, mapping, structure, function, and evolution of a genome. Furthermore, there has been growing popularity of genomics in cancer care for providing personalized medicines to the patients for the cure. In addition, genomic research can obtain several public targets, such as a reduction in health disparities. Therefore, the surge in genomics research is expected to fuel market growth over the forecast period.
  • Increasing Instances of Umbilical Cord Blood Cell Conservation – For instance, in Japan, approximately 36% of childbirth facilities presently provide umbilical cord blood cell storage to private biobanks, which is an increase from 15% in the past.

  • Escalating Count of Biobanks Globally - For instance, the worldwide number of biobanks reached around 130 by the end of 2018. Hence, the surge in the number of biobanks is expected to enlarge the market size over the forecast period.

  • Rising Cases of Hemophilia and Bleeding Disorders - Hemophilia is a disorder that interrupts the clotting of blood. It is a rare disorder that can develop in humans based on their genetics. For instance, between 2021 to 2022, approximately 200 thousand people were noticed to be living with hemophilia across the globe.

Challenges

  • Associated High Cost of Storage of Specimen Samples - The process of specimen sample storage in biobanks requires costly equipment, which in turn, makes the entire process of storage expensive. This factor is estimated to hinder the growth of the biobanking market.
  • Deficit in Counselling and Training on Medical Ethics
  • Misconceptions about Biobanking

Base Year

2025

Forecast Period

2026-2035

CAGR

8.5%

Base Year Market Size (2025)

USD 26.7 billion

Forecast Year Market Size (2035)

USD 60.37 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of biobanking is evaluated at USD 28.74 billion.

The global biobanking market size was worth over USD 26.7 billion in 2025 and is poised to grow at a CAGR of around 8.5%, reaching USD 60.37 billion revenue by 2035.

North America biobanking market will secure around 40.8% share by 2035, driven by the rising adoption of advanced technology and growing awareness regarding biobanking.

Key players in the market include UK Biobank Limited, Thermo Fisher Scientific Holdings, Inc., Tecan Trading AG, Hamilton Bonaduz AG, Bay Biosciences LLC., ISENET USA LLC, ASKION GmbH, Promega Corporation, VWR International, LLC., Merck KGaA.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos